Natriuretic Peptide Measurement Is Key to a Solution in the Clinical Trial and Clinical Practice

Mizuki Momoi; Yasuyuki Shiraishi; Shun Kohsaka; Keiichi Fukuda; Tsutomu Yoshikawa

doi:10.1016/j.jchf.2020.06.011

Natriuretic Peptide Measurement Is Key to a Solution in the Clinical Trial and Clinical Practice

Mizuki Momoi, Yasuyuki Shiraishi, Shun Kohsaka, Keiichi Fukuda, Tsutomu Yoshikawa

内科学(循環器)

研究成果: Letter › 査読

本文言語	English
ページ（範囲）	782-783
ページ数	2
ジャーナル	JACC: Heart Failure
巻	8
号	9
DOI	https://doi.org/10.1016/j.jchf.2020.06.011
出版ステータス	Published - 2020 9月

ASJC Scopus subject areas

循環器および心血管医学

文献へのアクセス

10.1016/j.jchf.2020.06.011

他のファイルとリンク

引用スタイル

@article{99e542a238b44ee2bc6de133f8d74897,

title = "Natriuretic Peptide Measurement Is Key to a Solution in the Clinical Trial and Clinical Practice",

author = "Mizuki Momoi and Yasuyuki Shiraishi and Shun Kohsaka and Keiichi Fukuda and Tsutomu Yoshikawa",

note = "Funding Information: Please note: The WETHF registry was supported by a grant from the Japan Agency for Medical Research and Development (201439013C), a Grant-in-Aid for Scientific Research (JPSS KAKENHI, 23591062, 26461088, and 17K09526), a Grant-in-Aid for Young Scientists (JPSS KAKENHI, 18K15860), a Grant-in-Aid for Clinical Research from the Japanese Circulation Society (2019), a Grant-in-Aid from the Japanese Ministry of Health, Labor and Welfare (H29-Refractory Disease-034), a Health Labour Science Research Grant (14528506), and Sakakibara Clinical Research Grant for the Promotion of Science (2012–2019). Dr. Shiraishi is affiliated with a department endowed by Nippon Shinyaku Co., Ltd.; has received a research grant from the SECOM Science and Technology Foundation; and has received an honorarium from Otsuka Pharmaceutical Co., Ltd. Dr. Kohsaka has received an unrestricted research grant from the Department of Cardiology, Keio University School of Medicine, Bayer Pharmaceutical Co., Ltd., and Daiichi Sankyo Co., Ltd. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2020",

month = sep,

doi = "10.1016/j.jchf.2020.06.011",

language = "English",

volume = "8",

pages = "782--783",

journal = "JACC: Heart Failure",

issn = "2213-1779",

publisher = "Elsevier BV",

number = "9",

}

TY - JOUR

T1 - Natriuretic Peptide Measurement Is Key to a Solution in the Clinical Trial and Clinical Practice

AU - Momoi, Mizuki

AU - Shiraishi, Yasuyuki

AU - Kohsaka, Shun

AU - Fukuda, Keiichi

AU - Yoshikawa, Tsutomu

N1 - Funding Information: Please note: The WETHF registry was supported by a grant from the Japan Agency for Medical Research and Development (201439013C), a Grant-in-Aid for Scientific Research (JPSS KAKENHI, 23591062, 26461088, and 17K09526), a Grant-in-Aid for Young Scientists (JPSS KAKENHI, 18K15860), a Grant-in-Aid for Clinical Research from the Japanese Circulation Society (2019), a Grant-in-Aid from the Japanese Ministry of Health, Labor and Welfare (H29-Refractory Disease-034), a Health Labour Science Research Grant (14528506), and Sakakibara Clinical Research Grant for the Promotion of Science (2012–2019). Dr. Shiraishi is affiliated with a department endowed by Nippon Shinyaku Co., Ltd.; has received a research grant from the SECOM Science and Technology Foundation; and has received an honorarium from Otsuka Pharmaceutical Co., Ltd. Dr. Kohsaka has received an unrestricted research grant from the Department of Cardiology, Keio University School of Medicine, Bayer Pharmaceutical Co., Ltd., and Daiichi Sankyo Co., Ltd. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2020/9

Y1 - 2020/9

UR - http://www.scopus.com/inward/record.url?scp=85089818346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089818346&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2020.06.011

DO - 10.1016/j.jchf.2020.06.011

M3 - Letter

C2 - 32883441

AN - SCOPUS:85089818346

VL - 8

SP - 782

EP - 783

JO - JACC: Heart Failure

JF - JACC: Heart Failure

SN - 2213-1779

IS - 9

ER -